GCT Director of Business Development, Nataliya Katsnelson spoke with the Global Business Reports editors about the benefits of conducting clinical research abroad and the recent changes in the industry. While the volume of research in the United States dominates other regions due to it’s market attractiveness for the companies worldwide, the obvious growth of international research is evident.
The interview was published in the GBR issue of United States Biopharmaceuticals 2019, which comprises the following related topics: R&D, Contract Services, Drug discovery, Regulations and compliance, and more.
The publication can be accessed via this link: https://www.gbreports.com/files/pdf/_2019/US_Biopharma_2019.pdf